Psychoneurobiology Research and Personalized Treatment of Schizophrenia
- PMID: 34945791
- PMCID: PMC8707393
- DOI: 10.3390/jpm11121319
Psychoneurobiology Research and Personalized Treatment of Schizophrenia
Abstract
Psychoneurobiological approaches have been used to develop effective treatments for unmet needs in schizophrenia, e [...].
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Higuchi Y., Sumiyoshi T., Tateno T., Nakajima S., Sasabayashi D., Nishiyama S., Mizukami Y., Takahashi T., Suzuki M. Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia. J. Pers. Med. 2021;11:327. doi: 10.3390/jpm11050327. - DOI - PMC - PubMed
-
- Barrera-Conde M., Ausin K., Lachén-Montes M., Fernández-Irigoyen J., Galindo L., Cuenca-Royo A., Fernández-Avilés C., Pérez V., de la Torre R., Santamaría E., et al. Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients. J. Pers. Med. 2021;11:160. doi: 10.3390/jpm11030160. - DOI - PMC - PubMed
-
- Paderina D.Z., Boiko A.S., Pozhidaev I.V., Bocharova A.V., Mednova I.A., Fedorenko O.Y., Kornetova E.G., Loonen A.J.M., Semke A.V., Bokhan N.A., et al. Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia. J. Pers. Med. 2021;11:181. doi: 10.3390/jpm11030181. - DOI - PMC - PubMed
-
- Nitta A., Izuo N., Hamatani K., Inagaki R., Kusui Y., Fu K., Asano T., Torii Y., Habuchi C., Sekiguchi H., et al. Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex. J. Pers. Med. 2021;11:607. doi: 10.3390/jpm11070607. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
